APO Research
Talk to an analyst

APO RESEARCH · REPORT

Health Products for The Elderly

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Health Products for The Elderly Market Outlook and Growth Opportunities 2026

26 December 2025203 pages

Choose your research edition.

Industry ResearchHealth Products for The Elderly Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Health Products for The Elderly Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Health Products for The Elderly Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Health Products for The Elderly Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Health Products for The Elderly Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Health Products for The Elderly market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Health Products for The Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Health Products for The Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Health Products for The Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Health Products for The Elderly market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Health Products for The Elderly market include Amway, Blackmores Limited, Danone, Glanbia Plc, GNC Holdings, LLC, Herbalife Nutrition Ltd., Nestlé SA, Novartis and Suntory Holdings Limited, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Health Products for The Elderly market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Health Products for The Elderly and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Health Products for The Elderly revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Health Products for The Elderly market.

Health Products for The Elderly Segment by Company

Amway

Blackmores Limited

Danone

Glanbia Plc

GNC Holdings, LLC

Herbalife Nutrition Ltd.

Nestlé SA

Novartis

Suntory Holdings Limited

USANA Health Sciences, Inc.

Bayer

Tongrentang

H&H Group

Xiamen Kindomway Group Company

Nestlé Health Science

By-health

PERFECT

INFINITUS

China New Era Group

Health Products for The Elderly Segment by Type

Nutritional Supplements

Vitamins and Minerals

Others

Health Products for The Elderly Segment by Application

Online Sales

Offline Sales

Health Products for The Elderly Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Health Products for The Elderly status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Health Products for The Elderly key companies, revenue, market share, and recent developments.

3. To split the Health Products for The Elderly breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Health Products for The Elderly market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Health Products for The Elderly significant trends, drivers, influence factors in global and regions.

6. To analyze Health Products for The Elderly competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Health Products for The Elderly market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Health Products for The Elderly and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Health Products for The Elderly.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Health Products for The Elderly industry.

Chapter 3: Detailed analysis of Health Products for The Elderly company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Health Products for The Elderly in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Health Products for The Elderly in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Health Products for The Elderly Industry Trends Table 2. Health Products for The Elderly Industry Drivers Table 3. Health Products for The Elderly Industry Opportunities and Challenges Table 4. Health Products for The Elderly Industry Restraints Table 5. Global Health Products for The Elderly Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Health Products for The Elderly Revenue Share by Company (2021-2026) Table 7. Global Health Products for The Elderly Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Health Products for The Elderly Key Company Manufacturing Base & Headquarters Table 9. Global Health Products for The Elderly Company, Product Type & Application Table 10. Global Health Products for The Elderly Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Health Products for The Elderly by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Nutritional Supplements Table 15. Significant Companies of Vitamins and Minerals Table 16. Significant Companies of Others Table 17. Global Health Products for The Elderly Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Health Products for The Elderly Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Health Products for The Elderly Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Health Products for The Elderly Sales Value Share by Type (2021-2026) Table 21. Global Health Products for The Elderly Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Online Sales Table 23. Significant Companies of Offline Sales Table 24. Global Health Products for The Elderly Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Health Products for The Elderly Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Health Products for The Elderly Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Health Products for The Elderly Sales Value Share by Application (2021-2026) Table 28. Global Health Products for The Elderly Sales Value Share by Application (2027-2032) Table 29. Global Health Products for The Elderly Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Health Products for The Elderly Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Health Products for The Elderly Sales Value Share by Region (2021-2026) Table 32. Global Health Products for The Elderly Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Health Products for The Elderly Sales Value Share by Region (2027-2032) Table 34. Global Health Products for The Elderly Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Health Products for The Elderly Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Health Products for The Elderly Sales Value Market Share by Country (2021-2026) Table 37. Global Health Products for The Elderly Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Health Products for The Elderly Sales Value Market Share by Country (2027-2032) Table 39. Amway Company Information Table 40. Amway Business Overview Table 41. Amway Health Products for The Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Amway Health Products for The Elderly Product Portfolio Table 43. Amway Recent Development Table 44. Blackmores Limited Company Information Table 45. Blackmores Limited Business Overview Table 46. Blackmores Limited Health Products for The Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Blackmores Limited Health Products for The Elderly Product Portfolio Table 48. Blackmores Limited Recent Development Table 49. Danone Company Information Table 50. Danone Business Overview Table 51. Danone Health Products for The Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Danone Health Products for The Elderly Product Portfolio Table 53. Danone Recent Development Table 54. Glanbia Plc Company Information Table 55. Glanbia Plc Business Overview Table 56. Glanbia Plc Health Products for The Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Glanbia Plc Health Products for The Elderly Product Portfolio Table 58. Glanbia Plc Recent Development Table 59. GNC Holdings, LLC Company Information Table 60. GNC Holdings, LLC Business Overview Table 61. GNC Holdings, LLC Health Products for The Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. GNC Holdings, LLC Health Products for The Elderly Product Portfolio Table 63. GNC Holdings, LLC Recent Development Table 64. Herbalife Nutrition Ltd. Company Information Table 65. Herbalife Nutrition Ltd. Business Overview Table 66. Herbalife Nutrition Ltd. Health Products for The Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Herbalife Nutrition Ltd. Health Products for The Elderly Product Portfolio Table 68. Herbalife Nutrition Ltd. Recent Development Table 69. Nestlé SA Company Information Table 70. Nestlé SA Business Overview Table 71. Nestlé SA Health Products for The Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Nestlé SA Health Products for The Elderly Product Portfolio Table 73. Nestlé SA Recent Development Table 74. Novartis Company Information Table 75. Novartis Business Overview Table 76. Novartis Health Products for The Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Novartis Health Products for The Elderly Product Portfolio Table 78. Novartis Recent Development Table 79. Suntory Holdings Limited Company Information Table 80. Suntory Holdings Limited Business Overview Table 81. Suntory Holdings Limited Health Products for The Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Suntory Holdings Limited Health Products for The Elderly Product Portfolio Table 83. Suntory Holdings Limited Recent Development Table 84. USANA Health Sciences, Inc. Company Information Table 85. USANA Health Sciences, Inc. Business Overview Table 86. USANA Health Sciences, Inc. Health Products for The Elderly Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. USANA Health Sciences, Inc. Health Products for The Elderly Product Portfolio Table 88. USANA Health Sciences, Inc. Recent Development Table 89. Bayer Company Information Table 90. Bayer Business Overview Table 91. Bayer Health Products for The Elderly Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Bayer Health Products for The Elderly Product Portfolio Table 93. Bayer Recent Development Table 94. Tongrentang Company Information Table 95. Tongrentang Business Overview Table 96. Tongrentang Health Products for The Elderly Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Tongrentang Health Products for The Elderly Product Portfolio Table 98. Tongrentang Recent Development Table 99. H&H Group Company Information Table 100. H&H Group Business Overview Table 101. H&H Group Health Products for The Elderly Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. H&H Group Health Products for The Elderly Product Portfolio Table 103. H&H Group Recent Development Table 104. Xiamen Kindomway Group Company Company Information Table 105. Xiamen Kindomway Group Company Business Overview Table 106. Xiamen Kindomway Group Company Health Products for The Elderly Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Xiamen Kindomway Group Company Health Products for The Elderly Product Portfolio Table 108. Xiamen Kindomway Group Company Recent Development Table 109. Nestlé Health Science Company Information Table 110. Nestlé Health Science Business Overview Table 111. Nestlé Health Science Health Products for The Elderly Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Nestlé Health Science Health Products for The Elderly Product Portfolio Table 113. Nestlé Health Science Recent Development Table 114. By-health Company Information Table 115. By-health Business Overview Table 116. By-health Health Products for The Elderly Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. By-health Health Products for The Elderly Product Portfolio Table 118. By-health Recent Development Table 119. PERFECT Company Information Table 120. PERFECT Business Overview Table 121. PERFECT Health Products for The Elderly Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. PERFECT Health Products for The Elderly Product Portfolio Table 123. PERFECT Recent Development Table 124. INFINITUS Company Information Table 125. INFINITUS Business Overview Table 126. INFINITUS Health Products for The Elderly Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. INFINITUS Health Products for The Elderly Product Portfolio Table 128. INFINITUS Recent Development Table 129. China New Era Group Company Information Table 130. China New Era Group Business Overview Table 131. China New Era Group Health Products for The Elderly Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. China New Era Group Health Products for The Elderly Product Portfolio Table 133. China New Era Group Recent Development Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Health Products for The Elderly Product Image Figure 2. Global Health Products for The Elderly Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Health Products for The Elderly Market Size (2021-2032) & (US$ Million) Figure 4. Global Health Products for The Elderly Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Nutritional Supplements Image Figure 8. Vitamins and Minerals Image Figure 9. Others Image Figure 10. Global Health Products for The Elderly Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Health Products for The Elderly Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Health Products for The Elderly Sales Value Share by Type (2021-2032) Figure 13. Online Sales Image Figure 14. Offline Sales Image Figure 15. Global Health Products for The Elderly Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Health Products for The Elderly Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Health Products for The Elderly Sales Value Share by Application (2021-2032) Figure 18. Global Health Products for The Elderly Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Health Products for The Elderly Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Health Products for The Elderly Sales Value (2021-2032) & (US$ Million) Figure 21. North America Health Products for The Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Health Products for The Elderly Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Health Products for The Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Health Products for The Elderly Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Health Products for The Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Health Products for The Elderly Sales Value (2021-2032) & (US$ Million) Figure 27. South America Health Products for The Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Health Products for The Elderly Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Health Products for The Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Health Products for The Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Nutritional Supplements
  • Vitamins and Minerals
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Amway
  • Blackmores Limited
  • Danone
  • Glanbia Plc
  • GNC Holdings, LLC
  • Herbalife Nutrition Ltd.
  • Nestlé SA
  • Novartis
  • Suntory Holdings Limited
  • USANA Health Sciences, Inc.
  • Bayer
  • Tongrentang
  • H&H Group
  • Xiamen Kindomway Group Company
  • Nestlé Health Science
  • By-health
  • PERFECT
  • INFINITUS
  • China New Era Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Health Products for The Elderly Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Health Products for The Elderly Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Health Products for The Elderly Market Dynamics
  1. 2.1 Health Products for The Elderly Industry Trends
  2. 2.2 Health Products for The Elderly Industry Drivers
  3. 2.3 Health Products for The Elderly Industry Opportunities and Challenges
  4. 2.4 Health Products for The Elderly Industry Restraints
3 Health Products for The Elderly Market by Company
  1. 3.1 Global Health Products for The Elderly Company Revenue Ranking in 2025
  2. 3.2 Global Health Products for The Elderly Revenue by Company (2021-2026)
  3. 3.3 Global Health Products for The Elderly Company Ranking (2024-2026)
  4. 3.4 Global Health Products for The Elderly Company Manufacturing Base and Headquarters
  5. 3.5 Global Health Products for The Elderly Company Product Type and Application
  6. 3.6 Global Health Products for The Elderly Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Health Products for The Elderly Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Health Products for The Elderly Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Health Products for The Elderly Market by Type
  1. 4.1 Health Products for The Elderly Type Introduction
  2. 4.1.1 Nutritional Supplements
  3. 4.1.2 Vitamins and Minerals
  4. 4.1.3 Others
  5. 4.2 Global Health Products for The Elderly Sales Value by Type
  6. 4.2.1 Global Health Products for The Elderly Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Health Products for The Elderly Sales Value by Type (2021-2032)
  8. 4.2.3 Global Health Products for The Elderly Sales Value Share by Type (2021-2032)
5 Health Products for The Elderly Market by Application
  1. 5.1 Health Products for The Elderly Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Health Products for The Elderly Sales Value by Application
  5. 5.2.1 Global Health Products for The Elderly Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Health Products for The Elderly Sales Value by Application (2021-2032)
  7. 5.2.3 Global Health Products for The Elderly Sales Value Share by Application (2021-2032)
6 Health Products for The Elderly Regional Value Analysis
  1. 6.1 Global Health Products for The Elderly Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Health Products for The Elderly Sales Value by Region (2021-2032)
  3. 6.2.1 Global Health Products for The Elderly Sales Value by Region: 2021-2026
  4. 6.2.2 Global Health Products for The Elderly Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Health Products for The Elderly Sales Value (2021-2032)
  7. 6.3.2 North America Health Products for The Elderly Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Health Products for The Elderly Sales Value (2021-2032)
  10. 6.4.2 Europe Health Products for The Elderly Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Health Products for The Elderly Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Health Products for The Elderly Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Health Products for The Elderly Sales Value (2021-2032)
  16. 6.6.2 South America Health Products for The Elderly Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Health Products for The Elderly Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Health Products for The Elderly Sales Value Share by Country, 2025 VS 2032
7 Health Products for The Elderly Country-level Value Analysis
  1. 7.1 Global Health Products for The Elderly Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Health Products for The Elderly Sales Value by Country (2021-2032)
  3. 7.2.1 Global Health Products for The Elderly Sales Value by Country (2021-2026)
  4. 7.2.2 Global Health Products for The Elderly Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Health Products for The Elderly Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Health Products for The Elderly Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Health Products for The Elderly Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amway
  2. 8.1.1 Amway Company Information
  3. 8.1.2 Amway Business Overview
  4. 8.1.3 Amway Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Amway Health Products for The Elderly Product Portfolio
  6. 8.1.5 Amway Recent Developments
  7. 8.2 Blackmores Limited
  8. 8.2.1 Blackmores Limited Company Information
  9. 8.2.2 Blackmores Limited Business Overview
  10. 8.2.3 Blackmores Limited Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Blackmores Limited Health Products for The Elderly Product Portfolio
  12. 8.2.5 Blackmores Limited Recent Developments
  13. 8.3 Danone
  14. 8.3.1 Danone Company Information
  15. 8.3.2 Danone Business Overview
  16. 8.3.3 Danone Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Danone Health Products for The Elderly Product Portfolio
  18. 8.3.5 Danone Recent Developments
  19. 8.4 Glanbia Plc
  20. 8.4.1 Glanbia Plc Company Information
  21. 8.4.2 Glanbia Plc Business Overview
  22. 8.4.3 Glanbia Plc Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Glanbia Plc Health Products for The Elderly Product Portfolio
  24. 8.4.5 Glanbia Plc Recent Developments
  25. 8.5 GNC Holdings, LLC
  26. 8.5.1 GNC Holdings, LLC Company Information
  27. 8.5.2 GNC Holdings, LLC Business Overview
  28. 8.5.3 GNC Holdings, LLC Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GNC Holdings, LLC Health Products for The Elderly Product Portfolio
  30. 8.5.5 GNC Holdings, LLC Recent Developments
  31. 8.6 Herbalife Nutrition Ltd.
  32. 8.6.1 Herbalife Nutrition Ltd. Company Information
  33. 8.6.2 Herbalife Nutrition Ltd. Business Overview
  34. 8.6.3 Herbalife Nutrition Ltd. Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Herbalife Nutrition Ltd. Health Products for The Elderly Product Portfolio
  36. 8.6.5 Herbalife Nutrition Ltd. Recent Developments
  37. 8.7 Nestlé SA
  38. 8.7.1 Nestlé SA Company Information
  39. 8.7.2 Nestlé SA Business Overview
  40. 8.7.3 Nestlé SA Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nestlé SA Health Products for The Elderly Product Portfolio
  42. 8.7.5 Nestlé SA Recent Developments
  43. 8.8 Novartis
  44. 8.8.1 Novartis Company Information
  45. 8.8.2 Novartis Business Overview
  46. 8.8.3 Novartis Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Health Products for The Elderly Product Portfolio
  48. 8.8.5 Novartis Recent Developments
  49. 8.9 Suntory Holdings Limited
  50. 8.9.1 Suntory Holdings Limited Company Information
  51. 8.9.2 Suntory Holdings Limited Business Overview
  52. 8.9.3 Suntory Holdings Limited Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Suntory Holdings Limited Health Products for The Elderly Product Portfolio
  54. 8.9.5 Suntory Holdings Limited Recent Developments
  55. 8.10 USANA Health Sciences, Inc.
  56. 8.10.1 USANA Health Sciences, Inc. Company Information
  57. 8.10.2 USANA Health Sciences, Inc. Business Overview
  58. 8.10.3 USANA Health Sciences, Inc. Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  59. 8.10.4 USANA Health Sciences, Inc. Health Products for The Elderly Product Portfolio
  60. 8.10.5 USANA Health Sciences, Inc. Recent Developments
  61. 8.11 Bayer
  62. 8.11.1 Bayer Company Information
  63. 8.11.2 Bayer Business Overview
  64. 8.11.3 Bayer Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bayer Health Products for The Elderly Product Portfolio
  66. 8.11.5 Bayer Recent Developments
  67. 8.12 Tongrentang
  68. 8.12.1 Tongrentang Company Information
  69. 8.12.2 Tongrentang Business Overview
  70. 8.12.3 Tongrentang Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Tongrentang Health Products for The Elderly Product Portfolio
  72. 8.12.5 Tongrentang Recent Developments
  73. 8.13 H&H Group
  74. 8.13.1 H&H Group Company Information
  75. 8.13.2 H&H Group Business Overview
  76. 8.13.3 H&H Group Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  77. 8.13.4 H&H Group Health Products for The Elderly Product Portfolio
  78. 8.13.5 H&H Group Recent Developments
  79. 8.14 Xiamen Kindomway Group Company
  80. 8.14.1 Xiamen Kindomway Group Company Company Information
  81. 8.14.2 Xiamen Kindomway Group Company Business Overview
  82. 8.14.3 Xiamen Kindomway Group Company Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Xiamen Kindomway Group Company Health Products for The Elderly Product Portfolio
  84. 8.14.5 Xiamen Kindomway Group Company Recent Developments
  85. 8.15 Nestlé Health Science
  86. 8.15.1 Nestlé Health Science Company Information
  87. 8.15.2 Nestlé Health Science Business Overview
  88. 8.15.3 Nestlé Health Science Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Nestlé Health Science Health Products for The Elderly Product Portfolio
  90. 8.15.5 Nestlé Health Science Recent Developments
  91. 8.16 By-health
  92. 8.16.1 By-health Company Information
  93. 8.16.2 By-health Business Overview
  94. 8.16.3 By-health Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  95. 8.16.4 By-health Health Products for The Elderly Product Portfolio
  96. 8.16.5 By-health Recent Developments
  97. 8.17 PERFECT
  98. 8.17.1 PERFECT Company Information
  99. 8.17.2 PERFECT Business Overview
  100. 8.17.3 PERFECT Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  101. 8.17.4 PERFECT Health Products for The Elderly Product Portfolio
  102. 8.17.5 PERFECT Recent Developments
  103. 8.18 INFINITUS
  104. 8.18.1 INFINITUS Company Information
  105. 8.18.2 INFINITUS Business Overview
  106. 8.18.3 INFINITUS Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  107. 8.18.4 INFINITUS Health Products for The Elderly Product Portfolio
  108. 8.18.5 INFINITUS Recent Developments
  109. 8.19 China New Era Group
  110. 8.19.1 China New Era Group Company Information
  111. 8.19.2 China New Era Group Business Overview
  112. 8.19.3 China New Era Group Health Products for The Elderly Revenue and Gross Margin (2021-2026)
  113. 8.19.4 China New Era Group Health Products for The Elderly Product Portfolio
  114. 8.19.5 China New Era Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst